Extracorporeal devices

T. Welte (Hanover, Germany)

Source: Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I
Disease area: Interstitial lung diseases

Slide presentationMultimedia files

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
T. Welte (Hanover, Germany). Extracorporeal devices. Annual Congress 2013 –Ceremony for ERS Research Award on Idiopathic Pulmonary Fibrosis (financially supported by InterMune) followed by Clinical Year in Review I

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Extracorporeal CO2 removal
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Extracorporeal therapies in sepsis: from toraymyxin to CPFA
Source: Annual Congress 2013 –PG3 Infections and critical patients: emerging problems and clinical strategies
Year: 2013



Extracorporeal assistance as bridge and as support during transplantation
Source: International Congress 2019 – Therapeutic breakthrough Year in review
Year: 2019


Extracorporeal ventilatory support
Source: ISSN=1025-448x, ISBN=1-904097-23-5, page=220
Year: 2002

Lung transplant bridge with extracorporeal devices (ECMO and Novalung)
Source: School Course 2012 - Lung Transplantation
Year: 2012


Extracorporeal membrane oxygenation
Source: Eur Respir Mon 2012; 55: 133-141
Year: 2012


Early physiotherapy in the clinical course of patients on Veno-Venous Extracorporeal Membrane Oxygenation.
Source: International Congress 2018 – Acutely hospitalised patients: physiotherapy interventions and assessment methods
Year: 2018


Extracorporeal membrane oxygenation as bridge in patients with non-iatrogenic massive hemoptysis
Source: Annual Congress 2012 - Infections and sepsis in the ICU
Year: 2012


Extracorporeal membrane oxygenation in awake patients as bridge to lung transplantation
Source: Annual Congress 2012 - Optimising outcomes after lung transplantation
Year: 2012

The EOLIA trial and ECMO in veno-venous extracorporeal membrane oxygenation therapy: where we are now and where to go
Source: International Congress 2019 – Extracorporeal membrane oxygenation now and in the future
Year: 2019


External radiofrequency as a novel extracorporeal therapy for emphysema
Source: Eur Respir J, 56 (5) 2001422; 10.1183/13993003.01422-2020
Year: 2020



Application of ultra-protective ventilation during extracorporeal membrane oxygenation – feasibility under real-world conditions
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017

Extracorporeal carbon dioxide removal
Source: Eur Respir Monogr 2016; 74: 200-208
Year: 2016


Therapeutic Bronchoscopy Under Extracorporeal Membrane Oxygenation (ECMO) Support: Case Series
Source: International Congress 2019 – New insights into pleural and bronchoscopic interventions
Year: 2019


Weaning from veno-venous extracorporeal membrane oxygenation (ECMO) after prolonged ECMO runtime - should patients be transferred to a specialized center?
Source: International Congress 2017 – Sepsis, infections, ARDS and beyond
Year: 2017

Case presentation: Extracorporeal CO2 removal and veno venous ECMO as bridge to transplantation in refractory hypercapnic respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020


Job‘s syndrome post extracorporeal membrane oxygenation (ECMO)
Source: Eur Respir J 2006; 28: Suppl. 50, 487s
Year: 2006

Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism
Source: Eur Respir J, 53 (4) 1801773; 10.1183/13993003.01773-2018
Year: 2019